The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population

The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population

OBJECTIVE: We aimed to compare the efficacy and tolerability of once-weekly alendronate 70 mg/weekly, risedronate 35 mg/weekly and raloxifene 60 mg/daily in the treatment of postmenopausal osteoporosis. STUDY DESIGN: Retrospective case-control study. 216 aged matched postmenopausal women with osteop...

Full description

Bibliographic Details
Main Authors: Mesut Öktem, İbrahim Esinler, Derya Eroğlu, Pınar Akkaya, Esra Kuşcu, Hulusi Zeyneloğlu
Format: Article
Language:English
Published: Medical Network 2007-04-01
Series:Gynecology Obstetrics & Reproductive Medicine
Subjects:
Osteoporosis, Alendronate, Risedronate, Raloxifene, Postmenopausal women
Online Access:http://gorm.com.tr/index.php/GORM/article/view/515

Internet

http://gorm.com.tr/index.php/GORM/article/view/515

Similar Items